| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $77.6M | -53.6% |
| Cost of Revenue | $58.1M | -42.4% |
| Gross Profit | $19.5M | -70.7% |
| R&D Expense | $45.0M | -26.7% |
| SG&A Expense | $21.7M | -45.9% |
| Operating Income | -$71.0M | -4.4% |
| Pre-tax Income | -$79.4M | +7.2% |
| Income Tax | -$496K | -151.8% |
| Net Income | -$78.9M | +7.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.5M | +3.6% |
| Accounts Receivable | $10.4M | -77.6% |
| Inventory | $4.1M | -78.0% |
| Current Assets | $37.1M | -58.6% |
| Total Assets | $47.3M | -62.2% |
| Current Liabilities | $194.3M | -2.2% |
| Total Liabilities | $198.2M | -3.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$39.7M | +15.9% |
| Capital Expenditures | $1.3M | -59.1% |
| Investing Cash Flow | $53.7M | +1834.7% |
| Financing Cash Flow | -$13.8M | -147.4% |
| Free Cash Flow | -$41.0M | +18.5% |
| Stockholders' Equity |
| -$151.0M |
| -86.8% |